R9	Appositive Attribute:T172 Head:T72
R10	Appositive Attribute:T172 Head:T74
R11	PredicateNominative Attribute:T108 Head:T76
R12	Anaphora Anaphor:T110 Antecedent:T77
R13	Anaphora Anaphor:T109 Antecedent:T110
R14	Anaphora Anaphor:T115 Antecedent:T13
R15	Anaphora Anaphor:T167 Antecedent:T73
R16	Anaphora Anaphor:T167 Antecedent:T15
R17	Anaphora Anaphor:T168 Antecedent:T171
T1	Drug 290 299	aliskiren
T2	Drug 305 312	TEVETEN
T5	Drug_Class 4132 4172	angiotensin-converting enzyme inhibitors
T6	Drug_Class 4177 4212	angiotensin II receptor antagonists
T10	Drug_Class 5084 5113	angiotensin receptor blockers
T11	Drug_Class 5115 5129	ACE inhibitors
T12	Drug 5134 5143	aliskiren
T17	Drug 4801 4808	TEVETEN
T19	Drug 5375 5382	TEVETEN
T20	Drug_Class 5393 5419	agents that affect the RAS
T22	Drug 5443 5452	aliskiren
T23	Drug 5458 5465	TEVETEN
T26	Drug 5506 5515	aliskiren
T27	Drug 5521 5528	TEVETEN
T32	Drug_Class 6750 6756	NSAIDs
T33	Drug_Class 6768 6794	selective COX-2 inhibitors
T34	Drug_Class 6801 6836	angiotensin II receptor antagonists
T35	Drug 6848 6858	eprosartan
T39	Drug 7043 7053	eprosartan
T40	Drug_Class 7058 7063	NSAID
T41	Drug_Class 7105 7140	angiotensin II receptor antagonists
T42	Drug 7152 7162	eprosartan
T43	Drug_Class 7201 7227	selective COX-2 inhibitors
T44	Drug_Class 7184 7190	NSAIDs
T49	Drug 4327 4334	TEVETEN
T56	Drug_Class 5001 5046	Dual Blockade of the Renin-Angiotensin System
T57	Drug_Class 1150 1194	drugs affecting the renin-angiotensin system
T58	Drug_Class 1435 1479	drugs affecting the renin-angiotensin system
T59	Drug_Class 6392 6416	calcium channel blockers
T60	Drug_Class 6502 6540	Non-Steroidal Anti-Inflammatory Agents
T61	Drug_Class 3831 3857	angiotensin II antagonists
T62	Drug_Class 4565 4591	angiotensin II antagonists
T63	Drug_Class 6551 6588	Selective Cyclooxygenase-2 Inhibitors
T64	Drug_Class 4389 4403	ACE inhibitors
T65	Drug_Class 1206 1229	antihypertensive agents
T66	Drug_Class 6252 6269	thiazide diuretic
T67	Drug_Class 6590 6606	COX-2 Inhibitors
T68	Drug 5653 5660	digoxin
T69	Drug_Class 3137 3146	diuretics
T70	Drug_Class 6674 6682	diuretic
T71	Drug 6271 6290	hydrochlorothiazide
T72	Drug 5946 5958	ketoconazole
T73	Drug 5689 5697	warfarin
T74	Drug 5963 5974	fluconazole
T75	Drug 0 7	TEVETEN
T76	Drug 39 46	TEVETEN
T77	Drug 164 171	TEVETEN
T78	Drug 861 868	TEVETEN
T79	Drug 1685 1692	TEVETEN
T80	Drug 2017 2024	TEVETEN
T81	Drug 3248 3255	TEVETEN
T82	Drug 9 19	eprosartan
T83	Drug 48 58	eprosartan
T84	Drug 2104 2114	Eprosartan
T85	Drug 2351 2361	eprosartan
T86	Drug 2497 2507	eprosartan
T87	Drug 2665 2675	eprosartan
T88	Drug 2747 2757	eprosartan
T89	Drug 2778 2788	eprosartan
T90	Drug 2859 2869	eprosartan
T91	Drug 5582 5592	Eprosartan
T92	Drug 5805 5815	eprosartan
T93	Drug 6063 6073	eprosartan
T94	Drug 6125 6135	eprosartan
T95	Drug 6155 6165	Eprosartan
T96	Drug 6293 6303	Eprosartan
T97	Drug 6418 6446	sustained-release nifedipine
T98	Drug 6092 6102	Ranitidine
T99	Drug_Class 1083 1099	antihypertensive
T100	Drug_Class 7078 7094	antihypertensive
T13	Drug_Class 433 479	drugs that act on the renin-angiotensin system
T15	Drug 5702 5711	glyburide
T185	SPAN 4928 4939	pregnancies
T106	ZeroArticleNP 30 36	tablet
T107	IndefiniteNP 72 112	a non-biphenyl non-tetrazole angiotensin
T108	ZeroArticleNP 101 141	angiotensin II receptor (AT1) antagonist
T109	PossessivePronoun 252 266	its components
T110	DemonstrativeNP 229 241	this product
T111	ZeroArticleNP 344 374	PRECAUTIONS, Drug Interactions
T112	DefiniteNP 487 518	the second and third trimesters
T113	DefiniteNP 963 993	the second and third trimester
T114	DemonstrativeNP 890 912	These adverse outcomes
T115	DemonstrativeNP 948 959	these drugs
T116	DefiniteNP 1107 1126	the first trimester
T117	IndefiniteNP 1200 1229	other antihypertensive agents
T118	DefiniteNP 1361 1377	the unusual case
T119	DefiniteNP 1514 1524	the mother
T120	DefiniteNP 1528 1546	the potential risk
T121	DefiniteNP 1550 1559	the fetus
T122	IndefiniteNP 1484 1504	a particular patient
T123	ZeroArticleNP 1422 1429	therapy
T124	DefiniteNP 1609 1639	the intra-amniotic environment
T125	PersonalPronoun 1701 1703	it
T126	DefiniteNP 1733 1743	the mother
T127	DefiniteNP 1788 1796	the week
T128	DefiniteNP 1909 1918	the fetus
T129	IndefiniteNP 2460 2479	a systemic exposure
T130	DemonstrativeNP 2437 2451	this oral dose
T131	DefiniteNP 2766 2800	the 1000 mg eprosartan/kg/day dose
T132	DefiniteNP 2894 2906	the exposure
T133	IndefiniteNP 3020 3057	an activated renin-angiotensin system
T134	ZeroArticleNP 3137 3146	diuretics
T135	DefiniteNP 3260 3273	the treatment
T136	DemonstrativeNP 3184 3200	These conditions
T137	DefiniteNP 3343 3354	the patient
T138	DefiniteNP 3375 3394	the supine position
T139	IndefiniteNP 3420 3443	an intravenous infusion
T140	DefiniteNP 3598 3616	the blood pressure
T141	IndefiniteNP 3462 3494	A transient hypotensive response
T142	IndefiniteNP 3502 3520	a contraindication
T143	DefiniteNP 3704 3744	the renin-angiotensin-aldosterone system
T144	IndefiniteNP 3676 3689	a consequence
T145	IndefiniteNP 3862 3875	some patients
T146	DemonstrativeNP 3877 3890	these changes
T147	ZeroArticleNP 3831 3857	angiotensin II antagonists
T148	ZeroArticleNP 3949 3956	therapy
T149	DefiniteNP 4005 4017	the activity
T150	DefiniteNP 4021 4061	the renin-angiotensin-aldosterone system
T151	ZeroArticleNP 4132 4172	angiotensin-converting enzyme inhibitors
T152	ZeroArticleNP 4177 4212	angiotensin II receptor antagonists
T153	ZeroArticleNP 4389 4403	ACE inhibitors
T154	IndefiniteNP 4596 4609	some patients
T155	DemonstrativeNP 4611 4624	these effects
T156	ZeroArticleNP 4565 4591	angiotensin II antagonists
T157	ZeroArticleNP 4665 4672	therapy
T158	DefiniteNP 4769 4785	the consequences
T159	PossessivePronoun 4943 4959	their physicians
T160	DefiniteNP 5071 5078	the RAS
T161	ZeroArticleNP 5084 5113	angiotensin receptor blockers
T162	ZeroArticleNP 5115 5129	ACE inhibitors
T163	ZeroArticleNP 5283 5294	monotherapy
T164	IndefiniteNP 5387 5419	other agents that affect the RAS
T165	DefiniteNP 5629 5649	the pharmacokinetics
T166	DefiniteNP 5665 5685	the pharmacodynamics
T167	DemonstrativeNP 5783 5795	these agents
T168	PossessivePronoun 5926 5940	its metabolism
T169	DefiniteNP 5838 5864	the cytochrome P450 system
T170	ZeroArticleNP 5866 5876	inhibitors
T171	ZeroArticleNP 5880 5893	CYP450 enzyme
T172	ZeroArticleNP 5976 5993	potent inhibitors
T173	ZeroArticleNP 6374 6416	sustained-release calcium channel blockers
T174	ZeroArticleNP 6502 6540	Non-Steroidal Anti-Inflammatory Agents
T175	ZeroArticleNP 6551 6588	Selective Cyclooxygenase-2 Inhibitors
T176	ZeroArticleNP 6590 6606	COX-2 Inhibitors
T177	ZeroArticleNP 6674 6690	diuretic therapy
T178	ZeroArticleNP 6768 6794	selective COX-2 inhibitors
T179	ZeroArticleNP 6801 6836	angiotensin II receptor antagonists
T180	DemonstrativeNP 6947 6960	These effects
T181	ZeroArticleNP 7064 7071	therapy
T182	DefiniteNP 7074 7101	The antihypertensive effect
T183	ZeroArticleNP 7105 7140	angiotensin II receptor antagonists
T184	ZeroArticleNP 7201 7227	selective COX-2 inhibitors
